ANI Pharmaceuticals Inc (ANIP)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	46,971	42,065	19,122	-6,193	-35,283	-60,826	-59,393	-62,033	-39,793	-15,739	-9,375	-5,129	-16,016	-21,018	-16,492	4,107	16,351	32,467	35,253	33,224
Total assets	US$ in thousands	904,422	889,914	859,341	765,224	760,087	739,110	751,334	744,846	771,598	470,454	480,159	463,843	461,190	462,581	465,391	482,232	456,789	456,775	446,906	434,390
Operating ROA		5.19%	4.73%	2.23%	-0.81%	-4.64%	-8.23%	-7.91%	-8.33%	-5.16%	-3.35%	-1.95%	-1.11%	-3.47%	-4.54%	-3.54%	0.85%	3.58%	7.11%	7.89%	7.65%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $46,971K ÷ $904,422K
= 5.19%

ANI Pharmaceuticals Inc's operating return on assets (operating ROA) has shown a mixed performance over the past eight quarters. The operating ROA increased from negative values in Q1 2022 to reach positive levels in the subsequent quarters, peaking at 5.48% in Q4 2023. This upward trend indicates an improvement in the company's operating efficiency and profitability relative to its assets.

The operating ROA fluctuated over the period, with the highest value of 5.48% in Q4 2023 and the lowest at -7.13% in Q2 2022. This variability suggests potential volatility in ANI Pharmaceuticals' operating performance and asset utilization efficiency.

Overall, the positive operating ROA values in the most recent quarters indicate that ANI Pharmaceuticals has been more effective in generating operating profits relative to its assets. However, the company should continue to monitor and strive for consistent improvement in its operating ROA to ensure sustainable profitability and efficient asset utilization.